Park Medi World marked its stock market debut on December 17, 2025, with a subdued opening on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The healthcare services provider’s shares were listed at ₹158 on the NSE, reflecting a 2.5% decline from the IPO issue price of ₹162. On the BSE, the stock opened at ₹155.60, translating into a steeper discount of 3.95%.
The listing followed the successful conclusion of the company’s initial public offering, which raised a total of ₹920 crore and attracted healthy participation across investor categories.
IPO Structure and Fundraising Details
Park Medi World’s IPO comprised a mix of a fresh issue and an offer for sale. The public issue included a fresh issuance of 4.75 crore equity shares amounting to ₹770 crore, along with an offer for sale of 0.93 crore shares worth ₹150 crore. The price band for the IPO was set between ₹154 and ₹162 per share.
Ahead of the IPO opening, the company secured ₹276 crore from anchor investors on December 9, 2025, providing early institutional backing to the issue.
Subscription Response Across Investor Categories
The Park Medi World IPO witnessed solid demand during its three-day subscription window. By the close of bidding, the issue was subscribed 8.53 times overall. The non-institutional investor segment saw the strongest interest, subscribing 15.93 times, while qualified institutional buyers subscribed 12.07 times. Retail investors also participated actively, with their portion booked 3.32 times.
In total, bids were received for 33.88 crore shares against the 3.97 crore shares on offer, underscoring broad-based investor participation.
Use of IPO Proceeds
The company has outlined a clear deployment plan for the funds raised through the fresh issue. A significant portion, amounting to ₹380 crore, is earmarked for the repayment of borrowings taken by Park Medi World and its subsidiaries. An additional ₹60.50 crore will be used to establish a new hospital and expand existing healthcare facilities, including those operated by its subsidiary.
Further, ₹27.46 crore has been allocated for the procurement of medical equipment. The remaining funds will be applied towards general corporate purposes and potential inorganic expansion opportunities that are yet to be finalised.
Company Overview and Operational Footprint
Park Medi World is the second-largest private hospital operator in North India and the largest private hospital chain in Haryana by bed capacity, as of March 31, 2025. The company operates 14 NABH-accredited, multi-super speciality hospitals under the ‘Park’ brand, with a total installed capacity of approximately 3,000 beds.
Over the past two years, Park Medi World has undertaken a notable expansion of its infrastructure. Its total bed capacity increased from 2,550 beds as of March 31, 2023, to 3,250 beds by September 30, 2025. The expansion momentum is expected to continue, with new hospitals currently under development in locations such as Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur and Kanpur.
Financial Performance Snapshot
Financially, the company reported an improvement in profitability in FY25, posting a profit of ₹213 crore compared with ₹152 crore in FY24. This performance, however, remained below the ₹228 crore reported in FY23. Revenue growth has been steady, rising to ₹1,426 crore in FY25 from ₹1,263 crore in FY24 and marginally above ₹1,272 crore recorded in FY23.
Also Read:
- Corona Remedies IPO Delivers a Strong Market Debut with 38% Listing Premium
- Aequs IPO: Shares Begin Trade with Nearly 13% Listing Premium
- Vidya Wires IPO: Shares List Flat at ₹52 in a Muted Market Debut
- Meesho IPO: Stellar Market Debut as Stock Lists Nearly 46% Above Issue Price
- Sudeep Pharma IPO: Shares Make Strong Debut with Over 23% Listing Premium
Conclusion
Park Medi World’s IPO debut reflects a cautious market response, with shares listing below the issue price despite healthy subscription levels and strong institutional participation. The company enters the public markets with a growing hospital network, expanding capacity, and a clearer focus on balance sheet strengthening and operational expansion. Its post-listing journey will be closely tracked as it continues to scale its healthcare footprint across North India.
If you are exploring more investment opportunities, check out our dedicated page on upcoming IPO listings to stay updated on the latest market offerings.
